Latest news
Lexeo Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for LX2020 for the Treatment of PKP2 Arrhythmogenic Cardiomyopathy - finance.yahoo.comfinance.yahoo.com · Wed, 05 Aug 2026 11:00:00 GMTClearPoint Neuro Congratulates Partner Aspen Neuroscience on FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel - finance.yahoo.comfinance.yahoo.com · Fri, 31 Jul 2026 07:00:00 GMTAspen Neuroscience Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel (ANPD001) to Treat Parkinson's Disease - PR NewswirePR Newswire · Thu, 30 Jul 2026 07:00:00 GMTInstinct Bio Announces Strategic Collaboration With INVITRX to Expand GENREVER Into U.S. and Advance Indonesia Regenerative Medicine Initiatives - finance.yahoo.comfinance.yahoo.com · Thu, 30 Jul 2026 07:00:00 GMTCastle Rock Regenerative Healthcare brings advanced Stem Cell Therapy and Regenerative Medicine to PHL - BusinessMirrorBusinessMirror · Thu, 30 Jul 2026 07:00:00 GMTAllogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Cemacabtagene Ansegedleucel (Cema-Cel) as First-Line Consolidation Therapy for Large B-Cell Lymphoma - finance.yahoo.comfinance.yahoo.com · Wed, 29 Jul 2026 07:00:00 GMTInstinct Bio Secures $150 Mln Equity Funding To Advance Regenerative Medicine Platform & Strategic Growth - TradingViewTradingView · Tue, 28 Jul 2026 15:40:29 GMTInstinct Bio (Nasdaq: BIOT) Secures $150 Million Equity Funding to Advance Regenerative Medicine Platform and Strategic Growth - Yahoo Finance AustraliaYahoo Finance Australia · Tue, 28 Jul 2026 14:01:00 GMT